tiprankstipranks
Trending News
More News >
Biocryst Pharmaceuticals (BCRX)
NASDAQ:BCRX

BioCryst (BCRX) Revenue

Compare
2,223 Followers

BioCryst Revenue

BioCryst had a revenue of 131.53M in the quarter ending Dec 31, 2024, with 12.34%. This bring the company's revenue in the last twelve months to 450.71M, Decreased 9.24%. In the fiscal year ending Dec 31, 2024, BioCryst had annual revenue of 450.71M with 36.00% growth.
Revenue (ttm)
450.71M
Revenue Growth
36.00%
P/S Ratio
3.89
Revenue/Employee
$777,090
Employees
580
Market Cap
$1.75B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024450.71M119.30M+36.00%
Dec 31, 2023331.41M60.59M+22.37%
Dec 31, 2022270.83M113.66M+72.31%
Dec 31, 2021157.17M139.36M+782.38%
Dec 31, 202017.81M-31.02M-63.53%
Dec 31, 201948.84M28.18M+136.45%
Dec 31, 201820.65M-4.53M-18.00%
Dec 31, 201725.19M-1.17M-4.43%
Dec 31, 201626.35M-21.90M-45.39%
Dec 31, 201548.26M34.65M+254.62%
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis